Waters Corp
Most Recent
Do Analysts See Any Upside for Thermo Fisher Stock?
Of the 17 analysts covering Thermo Fisher Scientific (TMO), 14 recommend ” buy” or a higher rating, and three recommend “hold.”
Thermo Fisher Scientific’s Gross Margin Trends
In fiscal 2018 and fiscal 2019, Thermo Fisher Scientific (TMO) is expected to generate revenue of $24.08 billion and $25.19 billion, respectively, compared with revenue of $20.92 billion in fiscal 2017.
Analysts Remain Bullish on Illumina Stock
In November, of the 19 analysts covering Illumina (ILMN), 14 have given it “buy” or higher ratings, and five have given it “hold” ratings.
Understanding Illumina’s Gross Margin Trend
Illumina’s cost of product revenue increased from $173.0 million in the third quarter of 2017 to $184.0 million in the third quarter of 2018.
Understanding Illumina’s Geographical Performance
For 2018 and 2019, Illumina is expected to generate revenues of $3.33 billion and $3.80 billion, respectively.
What Waters Corporation’s Valuation Trend Indicates
In September, of the 15 analysts covering Waters Corporation (WAT) stock, ten have given it “holds.”
Exploring Waters Corporation’s Operational Performance
Waters Corporation (WAT) incurred selling and administrative expenses of $136.6 million in the second quarter.
A Look at TMO’s New High Pressure Ion Chromatography System
On February 27, 2018, Thermo Fisher Scientific (TMO) announced the launch of its new high-pressure Ion Chromatography System.
ROP’s Second-Largest Segment: Radio Frequency Technology
In 2015, ROP’s Radio Frequency Technology segment contributed ~28.9% to its total consolidated revenue and ~30.4% to its consolidated operating profit
Roper Technologies: Recent Acquisitions That Count
Since its inception, Roper Technologies (ROP) has followed an acquisition-based growth strategy. The company has acquired over 50 companies since 1981.
What Risks Does Roper Technologies Face?
Roper Technologies’ growth strategy includes acquisitions. Its growth largely depends on its ability to acquire and successfully integrate new businesses.
How Are IHI’s Holdings’ Moving Averages Trending?
IHI has 47 stocks in its portfolio. As of June 9, 2016, 94% of IHI’s stocks were trading above their 20-day moving averages.
Waters Introduces Symphony, Its New Data Pipeline Software
A top IHI performer on June 2, 2016, was Waters (WAT), which rose 0.9%. The company was in the news with the introduction of its new data pipeline software.
IHI’s Large-Cap Stocks Continue to Impress
IHI’s large-cap stocks have been impressive in their performances and have remained positive in May 2016.
As IHI Keeps Surging, Which Are the Top Performers?
The markets fell today as oil took a dive. The Dow Jones Industrial Average fell 0.6%, and the SPDR S&P 500 ETF (SPY) fell 0.5%.
Huntington Bancshares Landed at the Bottom of SPY on Merger Deal
Huntington Bancshares (HBAN) plunged 8.5% on Tuesday, January 26, after the bank announced its plan to acquire FirstMerit (FMER) in a deal worth $3.4 billion.
An Overview of Thermo Fisher Scientific’s Business Model
Thermo Fisher Scientific (TMO) has made a number of acquisitions over the years, resulting in the expansion of the company’s product portfolio with the inclusion of a number of premium brands.
Waters Led XLV’s Electronic Subgroup
Waters closed at $133.73 and was trading above its 100-day moving average price of $126.45, and it was also trading above its 20-day moving average price of $131.44.
Natus and Masimo Helped IHI’s Top Ten Small-Cap Stocks Outperform
Natus (BABY) gained 1.9% and closed at $39.90. The stock is trading below its 20-day, 50-day, and 100-day moving averages.
Top Ten Mid-Cap Stocks Outperformed SPY on October 12
Varian Medical Systems (VAR) fell by 1.5% and closed at $76.82 on October 12. The stock fell on profit booking, breaking its three-day upward trend.
Cantillon ups its stake in Fidelity National Information Services
Cantillon increased its position in Fidelity National Information Services Inc. (FIS), which now accounts for 9.58% of its total portfolio in 1Q 2014 from 6.8% in the prior quarter.
Cantillon Capital Management’s 1Q 2014 investment strategy
The New York–based Cantillon Capital Management filed its 13F for the first quarter of 2014. The size of the U.S. long portfolio slightly increased in the quarter, from $4.22 billion to $4.32 billion.
